Altered expression of neurotrophic factors in patients with major depression

Journal of Psychiatric Research

Volumn 42, Issue 14, 2008, Pages 1145-1153

  Otsuki, Koji ^a   Uchida, Shusaku ^a   Watanuki, Toshio ^a   Wakabayashi, Yusuke ^a   Fujimoto, Michiko ^a   Matsubara, Toshio ^a   Funato, Hiromasa ^a   Watanabe, Yoshifumi ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bipolar disorder; GDNF; Major depression; Neurotrophic factor; State marker

Indexed keywords

ARTEMIN; BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; NEURTURIN; PERSEPHIN;

ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADRENOCORTICOTROPIC HORMONE; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE EXPRESSION PROFILING; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROTROPHIN 3; NEURTURIN; RADIOIMMUNOASSAY; REMISSION, SPONTANEOUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 51449104158     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2008.01.010     Document Type: Article

References (71)

1. Airaksinen M.S., Titievsky A., and Saarma M. GDNF family neurotrophic factor signaling: four masters, one servant?. Molecular and Cellular Neurosciences 13 (1999) 313-325
2. Aloe L., Alleva E., and Fiore M. Stress and nerve growth factor: findings in animal models and humans. Pharmacology, Biochemistry, and Behavior 73 (2002) 159-166
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Press, Washington, DC
4. Arborelius L., Owens M.J., Plotsky P.M., and Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. The Journal of Endocrinology 160 (1999) 1-12
5. Baecker P.A., Lee W.H., Verity A.N., Eglen R.M., and Johnson R.M. Characterization of a promoter for the human glial cell line-derived neurotrophic factor gene. Brain Research 69 (1999) 209-222
6. Baloh R.H., Tansey M.G., Lampe P.A., Fahrner T.J., Enomoto H., Simburger K.S., et al. Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex. Neuron 21 (1998) 1291-1302
7. Barbany G., and Persson H. Regulation of neurotrophin mRNA expression in the rat brain by glucocorticoids. The European Journal of Neuroscience 4 (1992) 396-403
8. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., and Charney D.S. Hippocampal volume reduction in major depression. The American Journal of Psychiatry 157 (2000) 115-118
9. Burke R.E., Antonelli M., and Sulzer D. Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture. Journal of Neurochemistry 71 (1998) 517-525
10. Caetano S.C., Kaur S., Brambilla P., Nicoletti M., Hatch J.P., Sassi R.B., et al. Smaller cingulate volumes in unipolar depressed patients. Biological Psychiatry 59 (2006) 702-706
11. Castro L.M., Gallant M., and Niles L.P. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. Journal of Neurochemistry 95 (2005) 1227-1236
12. Ceyhan G.O., Bergmann F., Kadihasanoglu M., Erkan M., Park W., Hinz U., et al. The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitis. Gut 56 (2007) 534-544
13. Chao H.M., and McEwen B.S. Glucocorticoids and the expression of mRNAs for neurotrophins, their receptors and GAP-43 in the rat hippocampus. Brain Research 26 (1994) 271-276
14. Chen A.C., Eisch A.J., Sakai N., Takahashi M., Nestler E.J., and Duman R.S. Regulation of GFRalpha-1 and GFRalpha-2 mRNAs in rat brain by electroconvulsive seizure. Synapse 39 (2001) 42-50
15. Cotter D., Mackay D., Landau S., Kerwin R., and Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Archives of General Psychiatry 58 (2001) 545-553
16. Coulpier M., and Ibanez C.F. Retrograde propagation of GDNF-mediated signals in sympathetic neurons. Molecular and Cellular Neurosciences 27 (2004) 132-139
17. de Kloet E.R. Hormones, brain and stress. Endocrine Regulations 37 (2003) 51-68
18. Drevets W.C., Price J.L., Simpson Jr. J.R., Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386 (1997) 824-827
19. Duman R.S., and Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biological Psychiatry 59 (2006) 1116-1127
20. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Archives of General Psychiatry 54 (1997) 597-606
21. Dwivedi Y., Mondal A.C., Rizavi H.S., and Conley R.R. Suicide brain is associated with decreased expression of neurotrophins. Biological Psychiatry 58 (2005) 315-324
22. Eilat E., Mendlovic S., Doron A., Zakuth V., and Spirer Z. Increased apoptosis in patients with major depression: a preliminary study. Journal of Immunology 163 (1999) 533-534
23. Forlenza M.J., and Miller G.E. Increased serum levels of 8-hydroxy-2′-deoxyguanosine in clinical depression. Psychosomatic Medicine 68 (2006) 1-7
24. Gong L., Wyatt R.J., Baker I., and Masserano J.M. Brain-derived and glial cell line-derived neurotrophic factors protect a catecholaminergic cell line from dopamine-induced cell death. Neuroscience Letters 263 (1999) 153-156
25. Govindarajan A., Rao B.S., Nair D., Trinh M., Mawjee N., Tonegawa S., et al. Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 13208-13213
26. Hamidi M., Drevets W.C., and Price J.L. Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biological Psychiatry 55 (2004) 563-569
27. Hansson A.C., Cintra A., Belluardo N., Sommer W., Bhatnagar M., Bader M., et al. Gluco- and mineralocorticoid receptor-mediated regulation of neurotrophic factor gene expression in the dorsal hippocampus and the neocortex of the rat. The European Journal of Neuroscience 12 (2000) 2918-2934
28. Hisaoka K., Nishida A., Koda T., Miyata M., Zensho H., Morinobu S., et al. Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells. Journal of Neurochemistry 79 (2001) 25-34
29. Hock C., Heese K., Muller-Spahn F., Huber P., Riesen W., Nitsch R.M., et al. Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression. Molecular Psychiatry 5 (2000) 510-513
30. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 (2000) 477-501
31. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. Journal of Affective Disorders 62 (2001) 77-91
32. Ichihara M., Murakumo Y., and Takahashi M. RET and neuroendocrine tumors. Cancer Letters 204 (2004) 197-211
33. Ivanova S.A., Semke V.Y., Vetlugina T.P., Rakitina N.M., Kudyakova T.A., and Simutkin G.G. Signs of apoptosis of immunocompetent cells in patients with depression. Neuroscience and Behavioral Physiology 37 (2007) 527-530
34. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., and Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Research 109 (2002) 143-148
35. Khanzode S.D., Dakhale G.N., Khanzode S.S., Saoji A., and Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Report 8 (2003) 365-370
36. Knable M.B., Barci B.M., Webster M.J., Meador-Woodruff J., and Torrey E.F. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Molecular Psychiatry 9 (2004) 609-20,544
37. Kodama Y., Asai N., Kawai K., Jijiwa M., Murakumo Y., Ichihara M., et al. The RET proto-oncogene: a molecular therapeutic target in thyroid cancer. Cancer Science 96 (2005) 143-148
38. Kuloglu M., Atmaca M., Tezcan E., Gecici O., Tunckol H., and Ustundag B. Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiology 46 (2002) 27-32
39. Lopez J.F., Chalmers D.T., Little K.Y., and Watson S.J. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biological Psychiatry 43 (1998) 547-573
40. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. Journal of Neuroscience 20 (2000) 9104-9110
41. Matsubara T., Funato H., Kobayashi A., Nobumoto M., and Watanabe Y. Reduced glucocorticoid receptor alpha expression in mood disorder patients and first-degree relatives. Biological Psychiatry 59 (2006) 689-695
42. McEwen B.S. Effects of adverse experiences for brain structure and function. Biological Psychiatry 48 (2000) 721-731
43. Mocchetti I., Spiga G., Hayes V.Y., Isackson P.J., and Colangelo A. Glucocorticoids differentially increase nerve growth factor and basic fibroblast growth factor expression in the rat brain. Journal of Neuroscience 16 (1996) 2141-2148
44. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
45. Nibuya M., Takahashi M., Russell D.S., and Duman R.S. Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neuroscience Letters 267 (1999) 81-84
46. Ongur D., Drevets W.C., and Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 13290-13295
47. Ozcan M.E., Gulec M., Ozerol E., Polat R., and Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. International Clinical Psychopharmacology 19 (2004) 89-95
48. Pariante C.M., and Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biological Psychiatry 49 (2001) 391-404
49. Perlman W.R., Webster M.J., Kleinman J.E., and Weickert C.S. Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Biological Psychiatry 56 (2004) 844-852
50. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry 45 (1999) 1085-1098
51. Ranjekar P.K., Hinge A., Hegde M.V., Ghate M., Kale A., Sitasawad S., et al. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Research 121 (2003) 109-122
52. Riccardi C., Bruscoli S., and Migliorati G. Molecular mechanisms of immunomodulatory activity of glucocorticoids. Pharmacological Research 45 (2002) 361-368
53. Ridder S., Chourbaji S., Hellweg R., Urani A., Zacher C., Schmid W., et al. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. Journal of Neuroscience 25 (2005) 6243-6250
54. Roceri M., Hendriks W., Racagni G., Ellenbroek B.A., and Riva M.A. Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus. Molecular Psychiatry 7 (2002) 609-616
55. Rosa A.R., Frey B.N., Andreazza A.C., Cereser K.M., Cunha A.B., Quevedo J., et al. Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neuroscience Letters 407 (2006) 146-150
56. Sapolsky R.M., Romero L.M., and Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine Reviews 21 (2000) 55-89
57. Sawada H., Ibi M., Kihara T., Urushitani M., Nakanishi M., Akaike A., et al. Neuroprotective mechanism of glial cell line-derived neurotrophic factor in mesencephalic neurons. Journal of Neurochemistry 74 (2000) 1175-1184
58. Schulte-Herbruggen O., Chourbaji S., Ridder S., Brandwein C., Gass P., Hortnagl H., et al. Stress-resistant mice overexpressing glucocorticoid receptors display enhanced BDNF in the amygdala and hippocampus with unchanged NGF and serotonergic function. Psychoneuroendocrinology 31 (2006) 1266-1277
59. Sheline Y.I., Sanghavi M., Mintun M.A., and Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. Journal of Neuroscience 19 (1999) 5034-5043
60. Shimazu K., Zhao M., Sakata K., Akbarian S., Bates B., Jaenisch R., et al. NT-3 facilitates hippocampal plasticity and learning and memory by regulating neurogenesis. Learning and Memory (Cold Spring Harbor, NY) 13 (2006) 307-315
61. Smith M.A., Makino S., Kvetnansky R., and Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. Journal of Neuroscience 15 (1995) 1768-1777
62. Takebayashi M., Hisaoka K., Nishida A., Tsuchioka M., Miyoshi I., Kozuru T., et al. Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. The International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 9 (2006) 607-612
63. Toth G., Yang H., Anguelov R.A., Vettraino J., Wang Y., and Acsadi G. Gene transfer of glial cell-derived neurotrophic factor and cardiotrophin-1 protects PC12 cells from injury: involvement of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase pathways. Journal of Neuroscience Research 69 (2002) 622-632
64. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., and Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nature Neuroscience 9 (2006) 519-525
65. Ueyama T., Kawai Y., Nemoto K., Sekimoto M., Tone S., and Senba E. Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neuroscience Research 28 (1997) 103-110
66. Ugarte S.D., Lin E., Klann E., Zigmond M.J., and Perez R.G. Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. Journal of Neuroscience Research 73 (2003) 105-112
67. Verity A.N., Wyatt T.L., Hajos B., Eglen R.M., Baecker P.A., and Johnson R.M. Regulation of glial cell line-derived neurotrophic factor release from rat C6 glioblastoma cells. Journal of Neurochemistry 70 (1998) 531-539
68. Walz J.C., Andreazza A.C., Frey B.N., Cacilhas A.A., Cereser K.M., Cunha A.B., et al. Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder. Neuroscience Letters 415 (2007) 87-89
69. Webster M.J., Knable M.B., O'Grady J., Orthmann J., and Weickert C.S. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Molecular Psychiatry 7 (2002) 985-94,24
70. Wissel K., Wefstaedt P., Rieger H., Miller J.M., Lenarz T., and Stover T. Upregulation of glial cell line-derived neurotrophic factor and artemin mRNA in the auditory nerve of deafened rats. Neuroreport 17 (2006) 875-878
71. Zihlmann K.B., Ducray A.D., Schaller B., Huber A.W., Krebs S.H., Andres R.H., et al. The GDNF family members neurturin, artemin and persephin promote the morphological differentiation of cultured ventral mesencephalic dopaminergic neurons. Brain Research Bulletin 68 (2005) 42-53